ID

43210

Description

ODM derived from http://clinicaltrials.gov/ct2/show/NCT00334295?term=NCT00334295&rank=1

Lien

http://clinicaltrials.gov/ct2/show/NCT00334295?term=NCT00334295&rank=1

Mots-clés

  1. 16/02/2012 16/02/2012 -
  2. 13/04/2014 13/04/2014 - Julian Varghese
  3. 10/08/2014 10/08/2014 - Martin Dugas
  4. 20/09/2021 20/09/2021 -
Téléchargé le

20 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility NCT00334295 Metastatic Endometrial Carcinoma

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
18 Years and older
Description

Age

Type de données

boolean

Alias
UMLS CUI-1
C0001779
Female Gender
Description

Female Gender

Type de données

boolean

Alias
UMLS CUI-1
C0086287
Histologically confirmed, recurrent or metastatic endometrial carcinoma
Description

Metastatic endometrial carcinoma

Type de données

boolean

Alias
UMLS CUI-1
C0813148
Postmenopausal
Description

Postmenopausal

Type de données

boolean

Alias
UMLS CUI-1
C0232970
Hormonreceptor positive tumor
Description

Hormonreceptor positive tumor

Type de données

boolean

Alias
UMLS CUI-1
C1563119
Exclusion criteria
Description

Exclusion criteria

Alias
UMLS CUI-1
C0680251
Pre-treatment with Fulvestrant
Description

Pre-treatment with Fulvestrant

Type de données

boolean

Alias
UMLS CUI-1
C1550147
Previous endocrine therapy of the endometrial carcinoma
Description

Previous endocrine therapy

Type de données

boolean

Alias
UMLS CUI-1
C0262926
UMLS CUI-2
C0279025
Previous malignancy less than 3 years ago other than in situ carcinoma of the cervix, basal cell carcinoma or squamous carcinoma of the skin
Description

Previous malignancy

Type de données

boolean

Alias
UMLS CUI-1
C0262926
UMLS CUI-2
C0006826

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years and older
boolean
C0001779 (UMLS CUI-1)
Female
Item
Female Gender
boolean
C0086287 (UMLS CUI-1)
Metastatic endometrial carcinoma
Item
Histologically confirmed, recurrent or metastatic endometrial carcinoma
boolean
C0813148 (UMLS CUI-1)
Postmenopausal
Item
Postmenopausal
boolean
C0232970 (UMLS CUI-1)
Hormonreceptor positive tumor
Item
Hormonreceptor positive tumor
boolean
C1563119 (UMLS CUI-1)
Item Group
Exclusion criteria
C0680251 (UMLS CUI-1)
Pre-treatment with Fulvestrant
Item
Pre-treatment with Fulvestrant
boolean
C1550147 (UMLS CUI-1)
Previous endocrine therapy
Item
Previous endocrine therapy of the endometrial carcinoma
boolean
C0262926 (UMLS CUI-1)
C0279025 (UMLS CUI-2)
Previous malignancy
Item
Previous malignancy less than 3 years ago other than in situ carcinoma of the cervix, basal cell carcinoma or squamous carcinoma of the skin
boolean
C0262926 (UMLS CUI-1)
C0006826 (UMLS CUI-2)

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial